Related Experiment Video
Updated: Sep 2, 2025
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
18.9K
Utilizing the New Glucometrics: A Practical Guide to Ambulatory Glucose Profile Interpretation
John Doupis1,2, Edward S Horton3
1Department of Internal Medicine and Diabetes, Salamis Naval and Veterans Hospital, Salamis, Attiki, Greece.
Touchreviews in Endocrinology
|August 11, 2022
Summary
Continuous and flash glucose monitoring improve diabetes management by lowering A1c and reducing glucose variability. This guide helps interpret glucose data for better diabetes care in type 1 and type 2 diabetes mellitus.
Area of Science:
- Endocrinology
- Metabolic Diseases
- Medical Devices
Background:
- Continuous glucose monitoring (CGM) and flash glucose monitoring (FGM) systems are established tools for managing type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM).
- These technologies significantly lower glycated haemoglobin (HbA1c) levels and improve quality of life by reducing hypoglycaemia and hyperglycaemia.
- Glucose data from these devices enable detailed glycaemic profiling, essential for personalized diabetes management.
Purpose of the Study:
- To provide a practical guide for interpreting new glucometrics derived from CGM and FGM data.
- To outline an algorithm and visual examples for understanding glycaemic profiles.
- To facilitate setting forward-looking diabetes management goals based on objective glucose data.
Main Methods:
- Utilizing data from continuous glucose monitoring and flash glucose monitoring systems.
- Applying an International Consensus Panel's agreed-upon targets for glucose control.
- Generating and analyzing ambulatory glucose profiles (AGPs) to identify patterns and trends.
Main Results:
- Established targets for glucose control exist for various patient groups, including children, adolescents, adults with T1DM, adults with T2DM, older adults, and pregnant women with T1DM.
- Ambulatory glucose profiles visually summarize dense glucose data, highlighting daily glucose control patterns.
- The interpretation of these new glucometrics can be demystified through a straightforward algorithm and clear visual examples.
Conclusions:
- CGM and FGM data, when interpreted using established targets and new glucometrics, offer a comprehensive view of glycaemic health.
- This approach supports informed decision-making for optimizing diabetes management strategies.
- The practical guidance presented aims to empower healthcare providers and patients in achieving better diabetes control and improving outcomes.
Related Concept Videos
01:15Hypoglycemia and Glucagon
318
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
318
01:14SBAR II: Application of SBAR
4.6K
SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
4.6K
01:15Diabetes: Symptoms, Diagnosis, and Complications
668
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
668
01:22Diabetes Mellitus: Type 2 and Gestational
2.7K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.7K
01:06Oral Hypoglycemic Agents: Glinides
241
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
241
01:02Glucose Homeostasis: Regulation of Blood Glucose
2.3K
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
2.3K